WNY1613 is a potent and selective PI3Kdelta inhibitor with piperazinone-containing purine scaffold. WNY1613 induces cancer cell apoptosis and inhibits the phosphorylation of PI3K downstream components in NHL cell lines. WNY1613 exhibits anti-NHL activity in vitro and in vivo[1].
Molecular Weight:
557.65
CAS Number:
[2650546-39-5]
Formula:
C29H35N9O3
Target:
Apoptosis,PI3K
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
